公司合作与研发进展 - Onco-Innovations Limited与专业聚合物工程及药物递送公司Nanosoft Polymers达成服务协议，以支持其先导纳米颗粒制剂PNKP抑制剂ONC010的持续开发 [1] - 根据协议，Nanosoft将为公司的专有PEO-PBCL聚合物平台提供聚合物工艺开发、分析表征、放大生产支持、配方优化和技术转移服务 [1] 产品管线 - 公司的先导候选药物为ONC010，是一种纳米颗粒配制的多核苷酸激酶磷酸酶抑制剂 [1]

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Next-Generation DNA Repair Therapies Open New Fro ...